1. Today is #WorldCancerDay our analysis led by @dr_mosama & @hvanspall academic.oup.com/ehjacc/advance… with @AnaBaracCardio @islamelgendy83 @DLBHATTMD @adnanalkhouli @safinmc @dataevan studies disparities in care & outcomes of cancer pts presenting with STEMI @DrMarthaGulati @ShrillaB
2. #WorldCancerDay It builds on our work published last year led by @adityadoc1 showing pts with cancer less likely to be managed invasively, and when they are have better outcomes. academic.oup.com/eurheartj/arti… @MKIttlesonMD @ovidiogarciav @DrPeterOKane @SukhNijjer @CardioIAN
3. #WorldCancerDay The greatest incidence of AMI in cancer pts is within 30d of Ca diagnosis, many treatments can ⬆️risk aswell as shared risk factors. We sought to study whether STEMI pts with cancer are less likley to get PPCI & whether they benefit academic.oup.com/ehjacc/advance…
4. #WorldCancerDay We used a propensity score matching approach to calculate the average treatment effect of PPCI in 5 cancers types (haematological, breast, colon, prostate and lung) and compare it to pts without cancer. Cancer pts upto 50% less likely to get PPCI @mirvatalasnag
6. #WorldCancerDay Why are pts with cancer less likely to get PPCI?
🥕⬆️bleeding risk: ⬇️Clotting , low platelets, bone marrow suppression
🥕 more co-morbid
🥕 Physician bias re expected benefit, with cancer pts excluded from RCTs
🥕 ⬆️ risk of thrombotic events
@mirvatalasnag
7. #WorldCancerDay what can we do to optimise outcomes during / post PPCI?
🥕 Consider / bleeding vs ischemic risk. Colon Ca⬆️bleeding, Lung CA ⬆️ischemic
🥕 #radialfirst
🥕 OCT/Image #imagefirst
🥕 use stent platforms that only require short dapt
🥕 short dapt with longer p2y12
8. #WorldCancerDay In summary- Pts with cancer have as much benefit from PPCI in STEMI but are 50% less likley to receive it. CVD disease is number 1 cause of death (other than cancer) in cancer pts @AnaBaracCardio @onco_cardiology #cardioncology #CardioOncology @VivekAgarwal

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Mamas Mamas

Mamas Mamas Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @mmamas1973

1 Nov 20
1. Clickbait title but content worth discussing- my thoughts over the next few tweets
➡️Questions around AMI definition.
Dr Taggart and others were part of the discussions that agreed to AMI definition. I think it was right because- see2.
medscape.com/viewarticle/93… via @medscape
2. an endpoint should have same prognostic impact in each trial arm. EXCEL definition does, UDMI doesnt
however:
➡️Should probably only include spontaneous AMI post procedure (>72 hrs), whatever definition you use, CABG better in long term
3. ➡️I personally dont think perceived COI have had any impact on the running / outcomes of the trial. Without industry support this trial would never have happened, nor would have many other fundamental trials. This is a smoke screen
Read 12 tweets
11 Oct 20
1. My talk today at #SHA2020 surgeon session re what #EXCEL really shows. To begin- need to understand importance of endpoints
➡️clinically relevant
➡️related to intervention
➡️relevant to pt
➡️similar prognostic impact in each arm
@SVRaoMD @ajaykirtane @RodrigoBagur @jedicath
2. A significant proportion of LMS wont be suitable for either surgery / CABG. As heart teams we have to do better in stratifying by extent of disease - 1/4 of pts included in #EXCEL didnt meet inclusion criteria (low/ intermediate risk) @ovidiogarciav @aspergian1 @cardioPCImom
3. The question of periporcedural AMI definition- depends on how you define re UDMI or protocol definition, will impact whether CABG 2x greater or 1/3 less. Personally i think protocol definition better as prognostic impact of AMI the same then in both arms (see pt 1)- BUT ➡️
Read 11 tweets
23 Jul 20
1. Our analysis of 144,000 deaths in UK during #COVID19 1st march-12th May published today mayoclinicproceedings.org/article/S0025-… . First national study of causes of death and underlying medical conditions. led by @dr_mosama with @dataevan @cpgale3 @TomLuscher only 25% of deaths due to COVID.
2. Age standardised mortality rates in UK ⬆️⬆️ for non-covid deaths than covid deaths during pandemic for all age groups @TheBHF @amibanerjee1 @DailyMailUK @guardian @ncurzen @ErinMichos @EricSecemskyMD @venkmurthy @DavidLBrownMD @BBCWorld @KeeleComms @AnastasiaSMihai @jcspratt
3. #COVID19 had the highest ASMR at each age group apart from young women where cancer was the commonest cause of death @SkyNews @Telegraph @Pooh_Velagapudi @poojaotherwise @adityadoc1 @onco_cardiology @mirvatalasnag @DrJenniferCo_Vu @jedicath @RodrigoBagur @VietHeartPA
Read 8 tweets
29 Jan 20
1. Our analysis of >70,000 pts with rheumatological disease undergoing pci (RA, SLA, SSC) led by @saraceciliamtz and @dr_mosama with collobaration with rheumatologists. 1.4% of pts have rheumaological diseases @DocSavageTJU @adityadoc1 @RodrigoBagur RA increasing over time
2. Patients with SLE have ⬆️ bleeding whilst pts with SSC highest risk, with ⬆️ mortality and stroke. Pts with RA not at increased risk once demographics adjusted. @Hragy @DBelardoMD @purviparwani @aspergian1 @stefan_harb @AnastasiaSMihai @drandrewsharp @billgogas @VijayKunadian
3. Summary slide. Analyses of nationwide databases provide a real- world vantage of outcomes on performed procedures, supplementing controlled trials and prospective cohorts and often answering questions on populations excluded from trials or at low prevalence. @mirvatalasnag
Read 4 tweets
1 Aug 19
1. Our work led by the v talented @Claire_A_Lawson with @kamleshkhunti et al studying 20 yr trends in outcomes in 88,000 pts with incident HF in UK. thelancet.com/journals/lanpu… Hospitalization rates ⬆️ particularly in areas of deprivation & older pts. @hvanspall @ShelleyZieroth
@Claire_A_Lawson @kamleshkhunti @hvanspall @ShelleyZieroth @GiuseppeGalati_ @bogdienache @DrMarthaGulati @purviparwani @AChoiHeart @onco_cardiology @avolgman @gina_lundberg @rwyeh @ErinMichos 2. >70% of Hospitalisations are non-CV. greater risk for those diagnosed in hospital vs community. Of CV causes of hospitalisation, HF related admissions becoming increasingly common. Data for mortality even more interesting ➡️ @iamritu @AnastasiaSMihai @mirvatalasnag @jedicath
Read 4 tweets
2 Dec 18
1. My Big Data talk in pci at #ICI18 meeting in Tel Aviv. Guidelines tell us to take comorbidity, cancer, frailty into account to guide practice, but not found in contemporary risk scores. Data from EHR can help guide. @DrMauricioCohen @Uqayyum123 @SmithElliotjs @jodiel0ve
2. Cardiologists have narrow view of comorbidity. consider individual conditions & not global comorbid burden. Non-CV death and readmissions more common than CV death following PCI. Driven by comorbidity. @mirvatalasnag @akhojaMD @Dralkutshan @jedicath @MBalghith @DocSavageTJU
3. Global comorbid burden such as Charlson, Elixhouser provide important prognostic information for PCI. 1 in 10 pts in PCI have a current or prior hx of cancer, yet we dont use any of this information in our risk models / to guide decisions. Unmet Need @DrFernandoCohen
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!